Edwards Lifesciences Corporation EW

86.29 0.56 0.65% as of 25 Sep
Market cap
$49.4B
P/E
49.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
46.33 10.61 32.71 30.31 53.53 69.29 46.47 44.53 40.31 35.78
P/S ratio
8.22 8.13 9.15 10.30 15.43 12.95 11.17 8.61 6.85 6.87
P/FCF ratio
38.20 170.25 72.83 48.44 57.60 88.78 53.71 46.78 28.74 42.11
P/Operating CF
110.57 (347.04) 335.64 162.56 216.14 142.07 120.59 109.41 64.66 101.17
P/B ratio
4.82 4.40 6.82 7.92 13.84 12.42 11.71 10.20 7.96 7.77
Price to Tangible BV
6.70 6.22 8.86 10.55 18.59 18.50 18.37 19.02 17.28 11.38
EV/Sales
7.62 7.52 8.95 10.17 15.27 12.77 10.97 8.67 6.76 6.71
EV/EBITDA
32.55 26.66 30.84 27.70 43.78 55.75 38.58 39.10 19.83 23.27
EV/Operating CF
28.99 75.41 50.05 37.25 46.13 53.13 40.31 34.84 23.21 28.25
EV/FCF
35.44 157.34 71.23 47.81 56.99 87.56 52.72 47.13 28.37 41.18
Quick Ratio
2.83 3.12 2.06 1.87 2.07 2.24 2.34 1.70 1.28 3.17
Current Ratio
3.72 4.18 3.38 3.03 3.08 3.46 3.31 2.61 1.80 4.21
Net Debt/EBITDA
(2.55) (2.20) (0.71) (0.36) (0.46) (0.78) (0.73) (0.44) (0.26) (0.52)
Debt/Assets
4.37% 4.58% 6.38% 7.50% 7.31% 8.59% 9.56% 11.15% 18.29% 18.23%
Debt/Equity
0.06 0.06 0.09 0.11 0.11 0.14 0.15 0.19 0.35 0.31
Asset Turnover
0.45 0.49 0.57 0.53 0.66 0.64 0.74 0.68 0.68 0.69
Operating CF/Net income
1.49 0.13 0.64 0.80 1.15 1.28 1.13 1.28 1.71 1.24
Capex/Depreciation
(1.66) (1.82) (1.84) (1.90) (2.45) (3.80) (3.12) (3.12) (2.14) (3.05)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
10.52% 49.75% 22.39% 26.14% 28.88% 18.88% 28.73% 23.69% 20.94% 22.24%
ROA
8.03% 37.24% 15.89% 18.12% 19.10% 12.00% 17.73% 13.14% 11.47% 13.30%
ROIC
11.78% 12.89% 14.39% 17.96% 21.17% 14.79% 22.04% 16.83% 25.64% 22.57%
Return on Tangible Assets
15.93% 64.56% 31.65% 41.06% 40.68% 22.92% 33.32% 31.71% 32.26% 24.90%
Average Days of Receivables
54.87 48.81 60.33 57.16 46.38 50.16 50.29 52.68 50.93 51.06
Research and Development Expense of Revenue
17.79% 19.36% 19.22% 18.90% 17.26% 17.34% 17.31% 16.71% 16.09% 14.92%
Selling, General and Administrative Expense of Revenue
34.37% 32.89% 31.59% 30.41% 28.55% 28.01% 28.57% 29.24% 28.84% 30.53%
Intangible Assets out of Total Assets
0.21 0.23 0.17 0.17 0.18 0.21 0.23 0.27 0.28 0.18
Share Based Compensation of Revenue
2.61% 2.98% 2.78% 2.84% 2.09% 2.11% 1.87% 1.91% 1.79% 1.92%
Graham Net Nets
0.07 0.07 0.03 0.01 0.01 0.01 0.01 0.00 (0.01) 0.02
Graham Number
27.05 51.42 23.99 22.74 22.58 14.75 15.81 11.36 9.85 9.06
Earnings Yield
2.16% 9.43% 3.06% 3.30% 1.87% 1.44% 2.15% 2.25% 2.48% 2.80%
Free Cash Flow Yield
2.62% 0.59% 1.37% 2.06% 1.74% 1.13% 1.86% 2.14% 3.48% 2.37%
Revenue per Share
10.38 9.10 8.26 7.21 8.39 7.05 6.96 5.93 5.43 4.64
Operating CF per Share
2.73 0.91 1.48 1.97 2.78 1.69 1.89 1.48 1.58 1.10
Capex per Share
(0.44) (0.47) (0.44) (0.43) (0.53) (0.65) (0.45) (0.39) (0.28) (0.34)
Free Cash Flow per Share
2.28 0.43 1.04 1.54 2.25 1.04 1.45 1.09 1.30 0.76
Cash per Share
7.23 6.65 2.69 1.96 2.35 2.25 2.43 1.52 2.11 1.99
Shareholders Equity per Share
17.68 16.84 11.08 9.38 9.36 7.35 6.64 5.00 4.67 4.10
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
17.68 16.84 11.08 9.38 9.36 7.35 6.64 5.00 4.67 4.10
Free Cash Flow
1,335.00 259.90 629.50 953.40 1,402.30 647.00 904.50 685.00 825.20 487.00
Working Capital
4,925.20 4,780.20 2,840.30 2,073.40 2,148.40 2,197.10 2,081.60 1,410.30 1,129.20 1,707.50
Capital Expenditures
(260.20) (282.40) (266.30) (264.80) (329.80) (407.30) (278.40) (241.70) (175.50) (217.40)
Net Current Asset Value
3,379.30 3,293.00 1,391.90 610.00 514.00 428.20 644.20 103.60 (161.00) 349.00
EV/EBIT
36.58 29.66 34.26 30.29 47.27 62.41 41.58 43.15 21.32 25.39
Capex to Sales
0.04 0.05 0.05 0.06 0.06 0.09 0.06 0.06 0.05 0.07
Net Profit Margin
17.69% 76.75% 27.99% 34.09% 28.73% 18.77% 24.08% 19.40% 16.99% 19.22%
Price to Operating Income
39.44 32.09 35.03 30.68 47.77 63.28 42.37 42.83 21.60 25.96
Other line items
Depreciation/Fixed assets
0.09 0.09 0.09 0.09 0.09 0.08 0.08 0.09 0.12 0.12
Cash ROIC
(1.43%) (7.81%) (7.77%) (5.42%) 2.34% (5.17%) 1.95% 1.26% 6.02% 2.64%
Accounts Receivable Turnover
7.40 6.99 6.56 6.55 8.26 7.30 7.65 7.32 7.69 7.54
Accounts Payable Turnover
6.28 5.82 5.04 3.56 6.23 5.73 7.09 7.50 8.19 9.91
Inventory Turnover
1.21 1.12 1.10 0.90 1.63 1.50 1.79 1.62 1.84 2.17
Average Days of Payables
62.24 64.48 69.61 101.83 59.77 66.37 59.09 52.07 48.62 44.45
Days of Inventory on Hand
308.10 354.94 337.06 441.56 212.38 271.00 209.91 235.85 231.39 181.54
Average Receivables
819.75 777.75 763.60 682.00 633.85 600.95 568.20 508.30 446.95 393.20
Average Payables
212.45 192.00 194.25 203.20 200.50 188.45 157.20 125.30 106.85 80.50
Average Inventory
1,106.45 995.10 889.50 801.10 764.50 721.60 623.95 580.95 475.75 368.25
Average Assets
13,376.25 11,209.25 8,827.85 8,397.55 7,869.85 6,862.60 5,905.90 5,495.05 5,088.20 4,283.15
Average Common Equity
10,200.25 8,391.15 6,263.05 5,821.30 5,205.10 4,361.30 3,644.35 3,048.30 2,787.60 2,561.05

Fold the line items

Columns are period end dates